Catecholamine-Based Treatment in AD Patients: Expectations and Delusions

In Alzheimer disease, the gap between excellence of diagnostics and efficacy of therapy is wide. Despite sophisticated imaging and biochemical markers, the efficacy of available therapeutic options is limited. Here we examine the possibility that assessment of endogenous catecholamine levels in cere...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefani, Alessandro, Olivola, Enrica, Liguori, Claudio, Hainsworth, Atticus H., Saviozzi, Valentina, Angileri, Giacoma, D’Angelo, Vincenza, Galati, Salvatore, Pierantozzi, Mariangela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418272/
https://www.ncbi.nlm.nih.gov/pubmed/25999852
http://dx.doi.org/10.3389/fnagi.2015.00067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418272/
https://www.ncbi.nlm.nih.gov/pubmed/25999852
http://dx.doi.org/10.3389/fnagi.2015.00067

Ejemplares similares